Partner for Years
UNISAFE PHARMA operates global state-of-the-art finished dosage form facilities in India that manufacture OSD, like tablets and capsules, across a wide range of therapeutic categories, such as antibacterials, antidiabetics, antiretrovirals, cardiovascular therapies and central nervous system agents.
UNISAFE PHARMA has a vast manufacturing platform in India which comprises active pharmaceutical ingredient (API) and oral solid dose (OSD) facilities that serve a number of markets around the world and produce medicines in a wide range of therapeutic areas.
Our facilities in India are approved by the U.S. Food and Drug Administration (FDA). Many of these sites also are approved and regularly inspected by other regulatory authorities, including World Health Organization.